Premium
Aromatic Extended Bisamidines: Synthesis, Inhibition of Topoisomerases, and Anticancer Cytotoxicity in Vitro
Author(s) -
Bielawski Krzysztof,
Bielawska Anna,
Wolczynski Slawomir
Publication year - 2001
Publication title -
archiv der pharmazie
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.468
H-Index - 61
eISSN - 1521-4184
pISSN - 0365-6233
DOI - 10.1002/1521-4184(200107)334:7<235::aid-ardp235>3.0.co;2-#
Subject(s) - cytotoxicity , topoisomerase , in vitro , chemistry , stereochemistry , pharmacology , combinatorial chemistry , biochemistry , biology
A series of four aromatic extended bisamidines ( 12‐15 ) differing in the nature of their terminal basic side chains were synthesized and evaluated for cytotoxic activity in MCF‐7 cultured breast cancer cells. The concentrations of 12, 13, 14, and 15 needed to inhibit [ 3 H]thymidine incorporation into DNA by 50% (IC 50 ) were found to be 63 μM, 85 μM, 77 μM, and 97 μM, respectively. To test whether cytotoxic properties were related to DNA‐binding and topoisomerase action, the bisamidines 12‐15 were evaluated in a cell‐free system. Data from the ethidium displacement assay showed that bisamidines 12‐15 have significant affinity for DNA and show moderate specificity for AT base pairs. In the topoisomerase II assay, the relaxation of DNA was inhibited with all four drugs and the extent of inhibition was directly proportional to the drug concentration. This suggests that DNA binding may be implicated in the cytotoxicity of these bisamidines, possibly by inhibiting interactions between topoisomerase II and their DNA targets.